Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

APLT Applied Therapeutics Inc

8,65

-0,04 (-0,46%)

19 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/09/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Shoshana Shendelman

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Applied Therapeutics Charts.

Applied Therapeutics (NASDAQ:APLT)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Applied Therapeutics Charts.

News Applied Therapeutics Inc

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Applied Therapeutics Reports Third Quarter 2024 Financial Results
Donnerstag 7 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
Dienstag 5 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
Mittwoch 18 September 2024 (2 Monate vor) • GlobeNewswire Inc.

Applied Therapeutics to Participate in Upcoming Investor Conferences
Mittwoch 4 September 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 23 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 15 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Applied Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen